Target intelligence / Profile preview

Catalyst

Molecular classification
Enzyme, Receptor
01

Overview

"Catalyst" is a fundamental biochemical term referring to a substance that increases the rate of a chemical reaction without undergoing any permanent chemical change itself. In the human body, the vast majority of biological catalysts are enzymes, which represent one of the most significant classes of therapeutic targets, including kinases, proteases, and polymerases [6, 11, 15]. While many specific targets function as catalysts, "Catalyst" is not a canonical name for a single protein, receptor, or gene. Instead, it serves as a functional classification for molecules that facilitate essential processes such as metabolism, signal transduction, and DNA replication [10, 11, 14]. The term is frequently encountered in the biotechnology sector within company names (e.g., Catalyst Pharmaceuticals, Catalyst Biosciences) or as a descriptive label for proteins like Protein Disulfide Isomerase (a protein-folding catalyst) or Atlastin-3 (a membrane fusion catalyst) [7, 8, 19]. It is also the name of established drug discovery software platforms, such as Accelrys Catalyst, used for pharmacophore modeling and virtual screening [8, 11]. Because "Catalyst" lacks specificity for a single molecular entity, it cannot be characterized by a unique set of interacting drugs or disease roles without reference to a specific enzymatic target. Analysts should identify the specific protein or enzyme (e.g., Catalase, Caspase-1, or a specific kinase) to obtain valid structured target information.

Other names
Biological catalystBiocatalystEnzymeCatalytic protein
02

Mechanism of action

Not applicable as "Catalyst" is a broad functional category rather than a specific molecular target. In biological systems, catalysts (primarily enzymes) lower the activation energy of reactions to facilitate physiological processes.

03

Biological functions

CatalysisMetabolismSignal transductionProtein foldingBiochemical reaction accelerationLowering activation energy
04

Safety considerations

Lack of target specificityBroad inhibition of catalytic functions leading to systemic toxicity

Beyond the preview

Go deeper on Catalyst.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Catalyst.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call